🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

59,53 USD

Máx. histórico

2.925,00

12010 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,96%

Rango 52 semanas

37,06 – 95,49

Variación hoy

-0,07%

Cierre anterior

59,57

Rango de hoy

59,25 – 60,89

Volumen hoy

1.327.132

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,88%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 6 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
03/11/2026 59,39 60,89 59,25 59,53 -0,07% 2,77% 1.327.132
02/11/2026 60,55 61,17 59,41 59,57 -0,55% 2,91% 1.313.700
30/10/2026 59,75 61,50 58,74 59,90 -0,98% 4,62% 1.124.500
29/10/2026 60,74 61,88 59,75 60,49 +0,47% 3,51% 1.274.400
28/10/2026 58,64 60,24 58,20 60,21 +2,00% 3,48% 1.247.900
27/10/2026 59,02 60,56 58,01 59,03 +0,08% 4,32% 2.118.800
26/10/2026 58,43 59,63 58,17 58,98 +1,65% 2,49% 979.800
23/10/2026 58,15 58,40 56,56 58,02 -0,58% 3,16% 871.700
22/10/2026 58,06 59,90 56,97 58,36 -0,82% 5,05% 1.036.500
21/10/2026 59,72 60,46 58,82 58,84 -0,14% 2,75% 1.371.500
20/10/2026 56,93 59,57 56,92 58,92 +2,95% 4,66% 1.742.300
19/10/2026 56,96 57,30 56,05 57,23 +2,38% 2,19% 1.647.000
16/10/2026 58,45 58,45 55,83 55,90 -4,44% 4,48% 1.772.800
15/10/2026 58,50 59,40 57,40 58,50 +0,22% 3,41% 2.009.600
14/10/2026 58,48 60,53 57,15 58,37 +0,41% 5,79% 4.160.100
13/10/2026 60,04 60,73 58,08 58,13 -4,28% 4,41% 2.260.400
12/10/2026 62,49 62,50 60,48 60,73 -3,22% 3,23% 1.194.400
09/10/2026 60,72 62,99 60,44 62,75 +3,31% 4,20% 2.765.700
08/10/2026 60,54 61,13 59,21 60,74 -1,20% 3,18% 1.784.700
07/10/2026 61,63 62,75 60,78 61,48 -0,10% 3,20% 1.819.200
06/10/2026 62,86 63,19 60,56 61,54 -1,30% 4,18% 1.675.500
05/10/2026 64,76 64,76 62,22 62,35 -2,87% 3,92% 2.249.400
02/10/2026 65,57 66,16 63,99 64,19 -0,93% 3,31% 1.487.600
01/10/2026 65,00 65,76 64,50 64,79 -1,01% 1,93% 1.521.700
30/09/2026 66,80 66,80 65,09 65,45 -1,21% 2,56% 1.742.700
29/09/2026 65,46 66,83 64,57 66,25 +1,21% 3,45% 2.869.600
28/09/2026 65,00 66,11 63,99 65,46 -0,70% 3,27% 1.589.700
25/09/2026 66,50 67,44 65,40 65,92 -0,23% 3,06% 1.616.200
24/09/2026 67,00 67,45 65,46 66,07 -1,33% 2,97% 1.626.300
23/09/2026 72,16 72,49 66,27 66,96 -6,82% 8,62% 2.554.500